Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

COGENT scientists uncover genes responsible for cognitive ability

An international team of scientists, led by Todd Lencz, PhD, professor at The Feinstein Institute for Medical Research at Northwell Health and Hofstra Northwell School of Medicine, have unlocked some of the genes responsible for cognitive ability.

17 Jan 2017

Epigenetic changes drive successful metastases of pancreatic cancer cells

A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells.

17 Jan 2017

Common drug for high blood pressure repurposed to treat soft tissue sarcoma in Europe

A drug that's commonly used to treat high blood pressure is being repurposed for a rare tissue cancer in Europe. The medication, named propranolol, was recently granted Orphan Drug Designation by the European Commission.

17 Jan 2017

Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

Each day, more than 1,600 people die from cancer in the US, and 450 in the UK, mostly because the disease has spread beyond a stage when surgery is an effective cure and has become resistant to therapy. Despite decades of research, understanding why cancer cells become invasive has remained shrouded in mystery.

17 Jan 2017

MGH researchers identify protein that may protect tumor-initiating cells in breast cancer

Massachusetts General Hospital investigators have identified a protein that may play an essential role in maintaining a population of tumor-initiating cells (TICs) -- treatment-resistant cells responsible for cancer recurrence and metastasis -- in breast cancer, as well as a compound that appears to reduce the molecule's ability to protect TICs from the effects of chemotherapy.

17 Jan 2017

Functional deficits caused by mini-strokes can last longer than previously thought

Evidence overwhelmingly supports a link between cognitive decline and cerebrovascular diseases such as atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy. Not only do individuals with cerebrovascular diseases have a much higher incidence of cortical microinfarcts (mini-strokes), but post-mortem histological and in vivo radiological studies also find that the burden of microinfarcts is significantly greater among people with vascular cognitive impairment and dementia (VCID) than in age-matched, non-demented individuals.

16 Jan 2017

Yoga may help improve quality of life in pediatric cancer patients, study reveals

Quality of life of patients doing yoga improved, according to the conclusions of “Results of a Pilot Yoga Intervention to Improve Pediatric Cancer Patients’ Quality of Life and Physical Activity and Parents' Well-being”.

16 Jan 2017

Study compares two common treatment options for pelvic organ prolapse

Pelvic organ prolapse occurs when the pelvic organs drop from their normal position in the pelvis.

12 Jan 2017

Technology and cost barriers hinder real-time reporting of cancer patients' symptoms

Capturing real-time reports of cancer patients' symptoms between doctor's visits has proven health benefits, but technology and cost barriers are getting in the way of widespread adoption of the practice, reports a University of North Carolina Lineberger Comprehensive Cancer Center researcher.

12 Jan 2017

Essen BioScience’s IncuCyte live-cell analysis platform cited in more than 1000 publications

The IncuCyte live-cell analysis platform from Essen BioScience has been cited in more than 1000 peer-reviewed publications since its introduction.

From Sartorius 12 Jan 2017

MUSC scientists design novel antibody-based therapy to fight against cancer

Scientists at the Medical University of South Carolina (MUSC) have designed an antibody-based therapy that could target the functions of TGF-beta that cause cancer

12 Jan 2017

Illumina and IBM join forces to grow accessibility to genome data interpretation

IBM Watson Health and Illumina, Inc. today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina’s BaseSpace Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation.

From Illumina, Inc. 11 Jan 2017

Roswell Park study provides new insights into gene mutations that can lead to cancer

Predisposition to cancer and cancer progression can result from gene mutations that cause elevated rates of genetic damage.

11 Jan 2017

Roswell Park researchers identify gene signatures that may help predict fatal prostate cancers

Standard therapy for prostate cancer, the third-leading cause of cancer-related deaths in American men, is based on blocking androgens, the male sex hormones.

11 Jan 2017

NCI launches new drug formulary to help expedite use of agents in clinical studies

The National Cancer Institute today launched a new drug formulary (the "NCI Formulary") that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials.

11 Jan 2017

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

The National Comprehensive Cancer Network has published the NCCN Guidelines for Patients and NCCN Quick Guide sheets for Brain Cancer - Gliomas—the first in a series of patient education resources focused on Brain Cancer.

10 Jan 2017

Study finds decline in rate of prostate cancer treatment after change in screening recommendations

As some national guidelines now recommend against routine prostate cancer screening, the overall rate of men receiving treatment for the disease declined 42 percent, a new study finds.

10 Jan 2017

Scientists crack genetic code to identify men at risk for prostate cancer that spreads after treatment

Canadian prostate cancer researchers have discovered the genetic fingerprint that explains why up to 30 per cent of men with potentially curable localized prostate cancer develop aggressive disease that spreads following radiotherapy or surgery.

10 Jan 2017

Landmark study unravels secrets of aggressive prostate cancer

A landmark study, led by Monash University's Biomedicine Discovery Institute with the involvement of the Peter MacCallum Cancer Centre, has revealed the reason why men with a family history of prostate cancer who also carry the BRCA2 gene fault have a more aggressive form of prostate cancer.

9 Jan 2017

UI scientists reveal how high-dose vitamin C damages cancer cells

Vitamin C has a patchy history as a cancer therapy, but researchers at the University of Iowa believe that is because it has often been used in a way that guarantees failure.

9 Jan 2017

Oncology News and Research

Further Reading

COGENT scientists uncover genes responsible for cognitive ability

Epigenetic changes drive successful metastases of pancreatic cancer cells

Common drug for high blood pressure repurposed to treat soft tissue sarcoma in Europe

Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

MGH researchers identify protein that may protect tumor-initiating cells in breast cancer

Functional deficits caused by mini-strokes can last longer than previously thought

Yoga may help improve quality of life in pediatric cancer patients, study reveals

Study compares two common treatment options for pelvic organ prolapse

Technology and cost barriers hinder real-time reporting of cancer patients' symptoms

Essen BioScience’s IncuCyte live-cell analysis platform cited in more than 1000 publications

MUSC scientists design novel antibody-based therapy to fight against cancer

Illumina and IBM join forces to grow accessibility to genome data interpretation

Roswell Park study provides new insights into gene mutations that can lead to cancer

Roswell Park researchers identify gene signatures that may help predict fatal prostate cancers

NCI launches new drug formulary to help expedite use of agents in clinical studies

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

Study finds decline in rate of prostate cancer treatment after change in screening recommendations

Scientists crack genetic code to identify men at risk for prostate cancer that spreads after treatment

Landmark study unravels secrets of aggressive prostate cancer

UI scientists reveal how high-dose vitamin C damages cancer cells

Industry Focus eBook - Oncology (3rd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News